{
  "ticker": "LLY",
  "target_date": "2025-03-18",
  "actual_date": "2025-03-18",
  "collected_at": "2025-12-08T11:31:52.009001",
  "price": {
    "open": 828.68,
    "high": 831.53,
    "low": 807.99,
    "close": 817.8275146484375,
    "volume": 2354900,
    "change_1d_pct": -0.27,
    "change_7d_pct": -5.41,
    "change_30d_pct": 1.67
  },
  "technicals": {
    "rsi_14": 29.46,
    "sma_20": 866.48,
    "sma_50": 826.82,
    "macd": -7.231,
    "macd_signal": 4.817,
    "macd_histogram": -12.047,
    "bb_upper": 952.82,
    "bb_lower": 780.13,
    "price_vs_sma20_pct": -5.61,
    "price_vs_sma50_pct": -1.09,
    "volume_ratio": 0.66
  },
  "fundamentals": {
    "market_cap": 889791643648,
    "pe_ratio": 48.63131,
    "forward_pe": 43.802517,
    "price_to_book": 37.37067,
    "price_to_sales": 14.974666,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.74,
    "pct_from_52w_low": 59.12
  },
  "macro": {
    "spy": {
      "price": 556.15,
      "change_1d_pct": -1.08,
      "change_7d_pct": 0.08
    },
    "vix": {
      "level": 21.7,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.28
    },
    "dollar_index": {
      "level": 103.24
    },
    "gold": {
      "price": 3035.1
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Eli Lilly (LLY) Stock Moves -0.27%: What You Should Know",
      "source": "Yahoo",
      "datetime": 1742334315,
      "summary": "Eli Lilly (LLY) concluded the recent trading session at $822.51, signifying a -0.27% move from its prior day's close.",
      "url": "https://finnhub.io/api/news?id=95d394236f95c12e0d7b307d991e16319dfbafdef343ddfd6a1198c6148e058d"
    },
    {
      "headline": "BlackRock Large Cap Focus Growth V.I. Fund Q4 2024 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1742333460,
      "summary": "The fund posted a return of 6.12% (Class I shares) for the fourth quarter of 2024. The largest exposures were in the IT, consumer discretionary, and communication services sectors.",
      "url": "https://finnhub.io/api/news?id=97cf50d37ed98fdb7cc4234b9fbfd82c53fdb3809751a6e52bfa678f67792145"
    },
    {
      "headline": "Eli Lilly And Company (LLY): Among Stocks to Buy That May Be Splitting Soon",
      "source": "Yahoo",
      "datetime": 1742332013,
      "summary": "We recently published a list of the 12 Stocks to Buy That May Be Splitting Soon. In this article, we are going to take a look at where Eli Lilly And Company (NYSE:LLY) stands against other stocks that may be splitting soon. Stock splits change the number of outstanding shares of a company, but not [",
      "url": "https://finnhub.io/api/news?id=e30a0bb5fc611f453951d01ecc006cbce9b6e307787f1c6adf4ac6127e90d8a4"
    },
    {
      "headline": "Eli Lilly (NYSE:LLY) Welcomes Circular Genomics To Gateway Labs For Advancing Alzheimer's Biomarker Research",
      "source": "Yahoo",
      "datetime": 1742320332,
      "summary": "Circular Genomics recently moved its headquarters to Lilly Gateway Labs, aiming to enhance its Alzheimer's disease diagnostics capabilities using advanced circRNA technologies. Eli Lilly (NYSE:LLY) experienced a 6% price increase over the last quarter, coinciding with this strategic move. The compan",
      "url": "https://finnhub.io/api/news?id=7ed384825bfd65ba0ca6988221776817a2d2ab6b62bf479ca80ae8f555a346aa"
    },
    {
      "headline": "Is Eli Lilly and Company (LLY) the Best Diabetes Stock to Buy According to Billionaires?",
      "source": "Yahoo",
      "datetime": 1742319567,
      "summary": "We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best diabetes stocks to buy according to billionaires. The Growing Market and Innovation in Continuous",
      "url": "https://finnhub.io/api/news?id=f3aff36fac934f46d2d727f43da53c458c980531ed4ce9ecb2651a5ffef754ae"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-03-13",
      "description": "xslF345X05/wk-form4_1741897046.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000091/xslF345X05/wk-form4_1741897046.xml"
    },
    {
      "form": "4",
      "date": "2025-03-04",
      "description": "xslF345X05/form4-03042025_040301.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000141588925006450/xslF345X05/form4-03042025_040301.xml"
    },
    {
      "form": "4",
      "date": "2025-03-03",
      "description": "xslF345X05/wk-form4_1741038785.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000083/xslF345X05/wk-form4_1741038785.xml"
    },
    {
      "form": "4",
      "date": "2025-03-03",
      "description": "xslF345X05/wk-form4_1741038712.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000081/xslF345X05/wk-form4_1741038712.xml"
    },
    {
      "form": "4",
      "date": "2025-02-26",
      "description": "xslF345X05/form4-02262025_040201.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000141588925005670/xslF345X05/form4-02262025_040201.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}